Inhibitors targeting SARS-CoV-2 proteases
Description
So far, vaccines are available to combat the Covid-19 pandemic, which can protect against a severe course, although part of society also does not want to be vaccinated or cannot do so due to pre-existing conditions. With a drug that can fight the virus in the organism, infected patients with severe symptoms would be helped. The aim of this project is to develop a small-molecule drug against SARS-CoV-2.
Key Data
Projectlead
Project team
Project status
completed, 10/2022 - 03/2024
Funding partner
Foundation
Einsiedlerstrasse 31
8820 Wädenswil